CELLTRAPPER Trademark

Trademark Overview

On Sunday, August 9, 2020, a trademark application was filed for CELLTRAPPER with the United States Patent and Trademark Office. The USPTO has given the CELLTRAPPER trademark a serial number of 90102137. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Vincera Pharma, Inc.. The CELLTRAPPER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; biologic preparations for the treatment of cancer
celltrapper

General Information

Serial Number90102137
Word MarkCELLTRAPPER
Filing DateSunday, August 9, 2020
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7207992
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; biologic preparations for the treatment of cancer
Pseudo MarkCELL TRAPPER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 10, 2020
Primary Code005
First Use Anywhere DateThursday, September 7, 2023
First Use In Commerce DateThursday, September 7, 2023

Trademark Owner History

Party NameVNRX Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameVNRX Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameVNRX Corp.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
Party NameVincera Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 21, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 19, 2023USE AMENDMENT FILED
Thursday, September 21, 2023SOU EXTENSION 4 GRANTED
Tuesday, September 19, 2023SOU EXTENSION 4 FILED
Tuesday, September 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 19, 2023TEAS STATEMENT OF USE RECEIVED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 22, 2023SOU EXTENSION 3 FILED
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 30, 2022SOU EXTENSION 2 FILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022CORRECTED NOA E-MAILED
Tuesday, March 15, 2022SOU EXTENSION 1 GRANTED
Thursday, March 3, 2022SOU EXTENSION 1 FILED
Tuesday, March 15, 2022DIVISIONAL PROCESSING COMPLETE
Thursday, March 3, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, March 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 20, 2021EXAMINER'S AMENDMENT ENTERED
Monday, September 20, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 20, 2021EXAMINERS AMENDMENT E-MAILED
Monday, September 20, 2021EXAMINERS AMENDMENT -WRITTEN
Sunday, September 19, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, September 19, 2021FINAL REFUSAL E-MAILED
Sunday, September 19, 2021FINAL REFUSAL WRITTEN
Thursday, August 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 6, 2021NON-FINAL ACTION E-MAILED
Friday, August 6, 2021NON-FINAL ACTION WRITTEN
Thursday, July 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2021ASSIGNED TO LIE
Wednesday, June 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 4, 2020NON-FINAL ACTION E-MAILED
Friday, December 4, 2020NON-FINAL ACTION WRITTEN
Thursday, December 3, 2020ASSIGNED TO EXAMINER
Thursday, September 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 12, 2020NEW APPLICATION ENTERED

Related Keywords

celltrapper cancer treatment preparations biologic pharmaceutical